NCT05696548 2026-04-09Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)National Cancer Center Hospital EastPhase 2 Active not recruiting51 enrolled
NCT03950609 2026-03-19Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid TumorsM.D. Anderson Cancer CenterPhase 2 Active not recruiting36 enrolled